Detalhe da pesquisa
1.
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study.
Oncologist
; 24(2): 185-192, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30190299
2.
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second-Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma.
Oncologist
; 22(3): 243-e23, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28246207
3.
Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
Oncologist
; 20(6): 615-6, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25926352
4.
Combining anti-VEGFR and anti-EGFR antibodies: Randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer:(ECOG-ACRIN E7208).
J Natl Cancer Inst
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38775718
5.
Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204.
Cancer
; 119(8): 1521-7, 2013 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23288663
6.
Disparities in Characteristics, Access to Care, and Oncologic Outcomes in Young-Onset Colorectal Cancer at a Safety-Net Hospital.
JCO Oncol Pract
; 17(5): e614-e622, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33428470
7.
Racial/Ethnic Disparities and Survival Characteristics in Non-Pancreatic Gastrointestinal Tract Neuroendocrine Tumors.
Cancers (Basel)
; 12(10)2020 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33076486
8.
Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation.
J Cell Physiol
; 218(1): 205-14, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18792914
9.
An open-label clinical trial evaluating safety and pharmacokinetics of two dosing schedules of panitumumab in patients with solid tumors.
Clin Colorectal Cancer
; 8(1): 29-37, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19203894
10.
Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution.
JCI Insight
; 52019 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31335328
11.
Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients.
Clin Cancer Res
; 25(2): 828-838, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30049749
12.
A Phase I Clinical Trial of the Phosphatidylserine-targeting Antibody Bavituximab in Combination With Radiation Therapy and Capecitabine in the Preoperative Treatment of Rectal Adenocarcinoma.
Am J Clin Oncol
; 41(10): 972-976, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28763330
13.
IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.
Mol Biol Cell
; 14(2): 585-99, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12589056
14.
Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65 subunit.
Clin Cancer Res
; 10(10): 3333-41, 2004 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15161687
15.
Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells.
Clin Cancer Res
; 9(4): 1291-300, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12684397
16.
Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference.
Clin Cancer Res
; 9(3): 931-46, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12631590
17.
Sulindac enhances tumor necrosis factor-alpha-mediated apoptosis of lung cancer cell lines by inhibition of nuclear factor-kappaB.
Clin Cancer Res
; 8(2): 354-60, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11839649
18.
When Phenotype Does Not Match Genotype-The Importance of Returning to the Raw Data.
J Appl Lab Med
; 4(3): 446-450, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31659084
19.
Fasting and Glucose-Stimulated Changes in Plasma Glucagon in Pancreatic Cancer: Potential Biomarkers for Detection?
Pancreas
; 48(1): e1-e3, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30531245
20.
Cells lacking IKKα show nuclear cyclin D1 overexpression and a neoplastic phenotype: role of IKKα as a tumor suppressor.
Mol Cancer Res
; 9(3): 341-9, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21317297